Herz-Kreislauf-Netz

Langendorfherz is a pioneering entity focused on advancing cardiovascular health through cutting-edge research and interdisciplinary collaboration. Based at the Universitätsklinikum Heidelberg, it brings together experts from various fields to tackle the complex genetic underpinnings of heart disease. The brand offers comprehensive studies on conditions such as hypertrophy, heart failure, and coronary artery disease, aiming to identify genetic risk factors and disease mechanisms.

Through innovative projects, Langendorfherz employs genomic methodologies and animal models to explore the genetic landscape of cardiovascular conditions, contributing to a deeper understanding of disease predisposition and progression. Their work includes investigating monogenic forms of heart conditions, the role of inflammation in disease pathogenesis, and the development of genomic predictors for heart failure following cancer treatments.

By addressing the critical intersection of genetics and cardiovascular health, Langendorfherz is dedicated to improving diagnostics and therapeutic strategies, ultimately aiming to reduce the burden of cardiovascular diseases, which remain a leading cause of mortality globally.